MAIA Biotechnology, Inc.

MAIA Healthcare Biotechnology

In the quarter to June 2026, EPS grew 27.8% and free cash flow fell 63.2%, each against the same quarter a year earlier. Insiders bought in the last twelve months.

1.10 0.02 −1.79%
Market cap
$69.2M
P/E
0.0×
Fwd P/E
—
Dividend yield
—
F-score
n/a
Altman Z
n/a
Beneish M
n/a
Dividend safety
n/a
Jun '26 Mar '26 Dec '25 Sep '25 Older periods
ROE
(218.68%) (148.29%) (745.24%) (2,691.01%)

+8 more TTM periods

ROA
(136.67%) (102.78%) (225.54%) (212.51%)
ROIC
0.00% 0.00% 0.00% 0.00%
Return on Tangible Assets
(122.14%) (83.64%) (579.39%) (1,268.92%)
Average Days of Receivables
— — — 0.00
Free Cash Flow per Share
(0.37) (0.44) (0.59) (0.47)
Free Cash Flow
(22.57) (19.95) (18.84) (15.73)
Other line items

Show all line items

Columns are period end dates